loader
Please Wait
Applying Filters...

Approved Marketing Authorisations (MA) containing Infliximab in Europe. Original Data : EMA Website

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2APS-Pharmaceuticals Parallel Import Service AG

02 1Celltrion Healthcare Hungary Kft

03 1Hospira UK Limited

04 1Janssen Biologics BV

05 1MSD Merck Sharp & Dohme AG

06 1Pfizer AG

07 2iQone Healthcare Switzerland SA

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Infliximab

Brand Name : Remicade (PI)

Dosage Form : Dry Sub

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Infliximab

Brand Name : Remsima (PI)

Dosage Form : Trockensub

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

infliximab

Brand Name : Remsima

Dosage Form : PULVER TILL KONCENTRAT TILL

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

infliximab

Brand Name : Inflectra

Dosage Form : POWDER FOR CONCENTRATE FOR

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

infliximab

Brand Name : Remicade

Dosage Form : POWDER FOR CONCENTRATE FOR

Dosage Strength : 100 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

06

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Infliximab

Brand Name : Remicade

Dosage Form : Dry Sub

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

Boulder Peptide 2024
Not Confirmed
arrow
arrow
Boulder Peptide 2024
Not Confirmed

Infliximab

Brand Name : Inflectra

Dosage Form : Dry Sub

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

08

iQone Healthcare Switzerland SA

Country
Boulder Peptide 2024
Not Confirmed
arrow

iQone Healthcare Switzerland SA

Country
arrow
Boulder Peptide 2024
Not Confirmed

Infliximab

Brand Name : Remsima

Dosage Form : Trockensub

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

09

iQone Healthcare Switzerland SA

Country
Boulder Peptide 2024
Not Confirmed
arrow

iQone Healthcare Switzerland SA

Country
arrow
Boulder Peptide 2024
Not Confirmed

Infliximab

Brand Name : Veblocema

Dosage Form : Inj L?s

Dosage Strength : 120mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank